Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
RNA-specific adenosine deaminase (ADAR1) catalyzes the deamination of adenosine to inosine in viral and cellular RNAs. Two size forms of the ADAR1 editing enzyme are known, an IFN-inducible ≈150-kDa protein and a constitutively expressed N-terminally truncated ≈110-kDa protein. We have now identified alternative exon 1 structures of human ADAR1 transcripts that initiate from unique promoters, one constitutively expressed and the other IFN inducible. Cloning and sequence analyses of 5′-rapid amplification of cDNA ends (RACE) cDNAs from human placenta established a linkage between exon 2 of ADAR1 and two alternative exon 1 structures, designated herein as exon 1A and exon 1B. Analysis of RNA isolated from untreated and IFN-treated human amnion cells demonstrated that exon 1B–exon 2 transcripts were synthesized in the absence of IFN and were not significantly altered in amount by IFN treatment. By contrast, exon 1A–exon 2 transcripts were IFN inducible. Transient transfection analysis with reporter constructs led to the identification of two functional promoters, designated P C and P I . Exon 1B transcripts were initiated from the P C promoter whose activity in transient transfection reporter assays was not increased by IFN treatment. The 107-nt exon 1B mapped 14.5 kb upstream of exon 2. The 201-nt exon 1A that mapped 5.4 kb upstream of exon 2 was initiated from the interferon-inducible P I promoter. These results suggest that two promoters, one IFN inducible and the other not, initiate transcription of the ADAR1 gene, and that alternative splicing of unique exon 1 structures to a common exon 2 junction generates RNA transcripts with the deduced coding capacity for either the constitutively expressed ≈110-kDa ADAR1 protein (exon 1B) or the interferon-induced ≈150-kDa ADAR1 protein (exon 1A).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., & Arnheim, N. (1985) · Science · doi:10.1126/science.2999980 · Cited by 8,956
Lodish, H. F. (1986) · Cited by 5,650
Frohman, M. A., Dush, M. K., & Martin, G. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8998 · Cited by 4,577
The scanning model for translation: an update.
Kozak, M. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.2.229 · Cited by 3,486
Der, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
Schibler, U., Wyler, T., & Hagenbüchle, O. (1975) · Journal of Molecular Biology · doi:10.1016/0022-2836(75)90217-x · Cited by 1,188
Cited by
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743
Self-citationInitiation of translation in prokaryotes and eukaryotes
Kozak, M. (1999) · Gene · doi:10.1016/s0378-1119(99)00210-3 · Cited by 1,364
RNA Editing by Adenosine Deaminases That Act on RNA
Bass, B. L. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135501 · Cited by 1,268
A-to-I editing of coding and non-coding RNAs by ADARs
Nishikura, K. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.4 · Cited by 1,041
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Ishizuka, J. J., Manguso, R. T., Cheruiyot, C. K., Bi, K., Panda, A., Iracheta-Vellve, A., Miller, B. C., Du, P. P., Yates, K. B., Dubrot, J., et al. (2019) · Nature · doi:10.1038/s41586-018-0768-9 · Cited by 697
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
Chung, H., Calis, J. J. A., Wu, X., Sun, T., Yu, Y., Sarbanes, S. L., Dao Thi, V. L., Shilvock, A. R., Hoffmann, H.-H., Rosenberg, B. R., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.038 · Cited by 538
“We generated ADAR1p150 KO cell lines by deleting the ADAR1p150-specific exon 1A and its IFN-inducible promoter (Figure 1A) (George and Samuel, 1999).”
InfluentialLiver Disintegration in the Mouse Embryo Caused by Deficiency in the RNA-editing Enzyme ADAR1
Hartner, J. C., Schmittwolf, C., Kispert, A., Müller, A. M., Higuchi, M., & Seeburg, P. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311347200 · Cited by 506
ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling
Hartner, J. C., Walkley, C. R., Lu, J., & Orkin, S. H. (2009) · Nature Immunology · doi:10.1038/ni.1680 · Cited by 490
ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis
Karki, R., Sundaram, B., Sharma, B. R., Lee, S., Malireddi, R. K. S., Nguyen, L. N., Christgen, S., Zheng, M., Wang, Y., Samir, P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109858 · Cited by 436
Awakening dormant haematopoietic stem cells
Trumpp, A., Essers, M., & Wilson, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2726 · Cited by 425
Predicting sites of ADAR editing in double-stranded RNA
Eggington, J. M., Greene, T., & Bass, B. L. (2011) · Nature Communications · doi:10.1038/ncomms1324 · Cited by 372
Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15
Okumura, A., Lu, G., Pitha-Rowe, I., & Pitha, P. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510518103 · Cited by 363
The dsRNA binding protein family: critical roles, diverse cellular functions
SAUNDERS, L. R., & BARBER, G. N. (2003) · The FASEB Journal · doi:10.1096/fj.02-0958rev · Cited by 338
Alu element‐mediated gene silencing
Chen, L., DeCerbo, J. N., & Carmichael, G. G. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.94 · Cited by 328
Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral
Samuel, C. E. (2011) · Virology · doi:10.1016/j.virol.2010.12.004 · Cited by 315
Self-citationDynamic association of RNA-editing enzymes with the nucleolus
Desterro, J. M. P., Keegan, L. P., Lafarga, M., Berciano, M. T., O'Connell, M., & Carmo-Fonseca, M. (2003) · Journal of Cell Science · doi:10.1242/jcs.00371 · Cited by 268
A-to-I RNA Editing and Human Disease
Maas, S., Kawahara, Y., Tamburro, K. M., & Nishikura, K. (2006) · RNA Biology · doi:10.4161/rna.3.1.2495 · Cited by 262
ADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity
Lamers, M. M., van den Hoogen, B. G., & Haagmans, B. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01763 · Cited by 229
“PKR is one of the best-studied ISGs and its expression inhibits the replication of a wide range of viruses (74).”
BackgroundInfluentialCRM1 Mediates the Export of ADAR1 through a Nuclear Export Signal within the Z-DNA Binding Domain
Poulsen, H., Nilsson, J., Damgaard, C. K., Egebjerg, J., & Kjems, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.22.7862-7871.2001 · Cited by 177
“coli strain BL21(DE3), yielding the proteins GST-(i)ADAR1(1-295) and GST-(i)ADAR1(1-295)NESmut.”
BackgroundRNA editing: Expanding the potential of RNA therapeutics
Booth, B. J., Nourreddine, S., Katrekar, D., Savva, Y., Bose, D., Long, T. J., Huss, D. J., & Mali, P. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.01.005 · Cited by 171
Rothenburg, S., Deigendesch, N., Dittmar, K., Koch-Nolte, F., Haag, F., Lowenhaupt, K., & Rich, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408714102 · Cited by 167
The p66Shc Longevity Gene Is Silenced through Epigenetic Modifications of an Alternative Promoter
Ventura, A., Luzi, L., Pacini, S., Baldari, C. T., & Pelicci, P. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200280200 · Cited by 162
Therapy Approaches for Stargardt Disease
Piotter, E., McClements, M. E., & MacLaren, R. E. (2021) · Biomolecules · doi:10.3390/biom11081179 · Cited by 49
Metadata
- Authors
- George, C. X., & Samuel, C. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-04-13
- Volume
- 96
- Issue
- 8
- Pages
- 4621-4626
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2163879429
- Cited by
- 341
- References
- 42
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.